Phase 1 Type 2 Diabetes Trial, Not Yet Recruiting NCT07670897 Sponsor: Gan & Lee Pharmaceuticals. Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Phase 1 Type 2 Diabetes Trial, Not Yet Recruiting

NCT07670897
Not Yet Recruiting Phase 1

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are willing to sign a consent form, receive injections under the skin, understand what the study involves, and follow the rules set out in the study plan.
  • Men aged between 18 and 50 years old (inclusive) at the time of signing the consent form.
  • People who weigh at least 50 kg and have a Body Mass Index (BMI) between 18.5 and 24.0 kg/m² at the screening stage (BMI is a measure of body weight relative to height).
  • Men who are capable of fathering children and who have no plans to conceive or donate sperm, and who are willing to use effective contraception from the time of signing the consent form until 4 weeks after receiving the study medication.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a history of significant allergies or allergic conditions such as asthma or eczema (except mild seasonal allergies), a history of severe food allergies (such as throat swelling or shock), a known allergy or sensitivity to the study drug or similar medicines, or a significant history of drug or skin allergies.
  • People whose results from physical check-ups, vital signs, standard blood or urine tests, heart tracings (ECG), chest scans, or other screening assessments are considered to be medically significant by the study doctor.
  • People who have specific dietary needs that would prevent them from following the standardised meal plan used in the study.
  • People who have a fear of needles or blood, have difficulty with blood draws, or cannot tolerate having blood taken from a vein.
  • People who are employees of the study doctor or trial centre, or are a family member of such an employee, or anyone the study doctor considers unsuitable for the trial for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026

Contact this trial

Phone: 010-56456739

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 1
Sponsor
Gan & Lee Pharmaceuticals.
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
29 July 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Cmax; AUC₀-t; AUC₀-∞

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov